Improving outcomes of cytomegalovirus (CMV) infection in recipients of haematopoietic stem cell transplantation (HSCT)

改善造血干细胞移植（HSCT）受者巨细胞病毒（CMV）感染的结果

• 批准号: nhmrc : GNT1161521
• 负责人: Dr Michelle Yong
• 金额: $ 34.85万
• 依托单位国家: 澳大利亚
• 项目类别: Early Career Fellowships
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/improving-outcomes-cytomegalovirus-transplantation-hsct/1349344
• 关键词: Improving; outcomes; cytomegalovirus; CMV; infection

Cytomegalovirus (CMV) infection is an important and common infectious complication in patients receiving stem cell transplantation. Control of the CMV virus is dependent on an intact immune system. This project seeks to evaluate the immune, viral and clinical factors in a large study of four Australian transplant centres in order to better identify at-risk patients and improve patient outcomes.

巨细胞病毒（CMV）感染是干细胞移植患者常见的感染性并发症。CMV病毒的控制依赖于完整的免疫系统。该项目旨在评估澳大利亚四个移植中心的大型研究中的免疫，病毒和临床因素，以便更好地识别高危患者并改善患者的预后。